Skip to main content

Table 1 Baseline comparison of patients

From: Is early-follicular long-acting GnRH agonist protocol an alternative for patients with polycystic ovary syndrome undergoing in vitro fertilization?

 

MLSL

EFLL

P value

 

n = 1179

N = 2390

/

Age (year)

28.883 ± 3.872

28.722 ± 3.752

0.239

Duration of infertility (year)

4.279 ± 2.747

4.146 ± 2.760

0.184

BMI (kg/m2)

24.330 ± 3.633

24.263 ± 3.448

0.595

LH (mIU/ml)

9.957 ± 6.655

9.630 ± 7.079

0.185

LH/FSH

1.718 ± 1.132

1.686 ± 1.152

0.433

E2(pg/ml)

41.457 ± 18.726

40.257 ± 17.760

0.064

T(ng/ml)

1.477 ± 7.125

1.081 ± 6.167

0.105

AMH (ng/ml)

7.764 ± 4.441

7.955 ± 4.381

0.539

FPG (mmol/l)

4.836 ± 0.445

4.859 ± 0.474

0.290

No. of cleavage transfer cycles (n)

n = 514

n = 1032

0.779

 1

17

37

 

 2

497

995

 

No. of blastocyst transfer cycles (n)

n = 140

n = 381

0.800

 1

139

379

 

 2

1

2

 
  1. Note: Continuous data: mean ± SD. Categorical data: % (n/N)
  2. BMI body mass index, HCG human chorionic gonadotropin, LH luteinizing hormone, FSH follicle-stimulating hormone, AMH anti-Müllerian hormone, FPG fasting plasma glucose